Electroporation: Technology and Science | SpringerLink

Chapter

Abstract

Enormous progress has been made in pulsed electric field-based therapies since the first reports describing the occurrence of electric field-induced transient pores in phospholipid bilayer vesicles. The term electroporation took some time to anchor within the vocabulary of the scientific community. Cell and tissue electroporation, visualized at the single-cell level, can be described as a succession of different steps. By a good selection of the pulses parameters, it is possible to induce a transient or irreversible permeabilization of the cell membrane, and to transfer non-permeant or poorly permeant molecules into cells and tissues. The development and current use of electroporation in oncology practice indeed highly benefitted from the understanding of the mechanisms and underlying biological processes of this method, from the optimization of pulses generators and electrodes, and from the standardization of the operating procedures. Classical electrochemotherapy and irreversible electroporation, already proved their efficacy to treat cancer both in human and veterinary clinics. Gene electrotransfer for immunotherapy and the combination of calcium ions with high-intensity electric field pulses, on another hand, have been developed in the last years, and are emerging as two additional clinical applications of electroporation.

Keywords

Electroporation Electrochemotherapy Veterinary oncology Membrane permeabilization Molecules delivery Cytotoxic drugs Companion animals Cancer treatment Technology Mechanisms 

Notes

Acknowledgments

The authors are very grateful to Dr. Jelena Kolosjnaj-Tabi for English corrections and to all their collaborators, post-doc, PhD, and Master students they have/had the pleasure to work with and who contributed so much in the elucidation of the process of electroporation and the development of its applications in clinics.

References

  1. Agoston D et al (2020) Evaluation of calcium electroporation for the treatment of cutaneous metastases: a double blinded randomised controlled phase II trial. Cancers 12(1):179

    PubMedCentralGoogle Scholar

  2. Aguilar-Machado D et al (2020) Enzymatic processes triggered by PEF for astaxanthin extraction from xanthophyllomyces dendrorhous. Front Bioeng Biotechnol 8:857

    PubMedPubMedCentralGoogle Scholar

  3. Allemani C et al (2018) Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 391(10125):1023–1075

    PubMedPubMedCentralGoogle Scholar

  4. Calvet CY, Mir LM (2016) The promising alliance of anti-cancer electrochemotherapy with immunotherapy. Cancer Metastasis Rev 35(2):165–177

    PubMedPubMedCentralGoogle Scholar

  5. Cemazar M et al (1999) Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin. Br J Cancer 79(9-10):1386–1391

    PubMedPubMedCentralGoogle Scholar

  6. Cemazar M et al (2008) Electrochemotherapy in veterinary oncology. J Vet Intern Med 22(4):826–831

    PubMedGoogle Scholar

  7. Cemazar M et al (2017) Efficacy and safety of electrochemotherapy combined with peritumoral IL-12 gene electrotransfer of canine mast cell tumours. Vet Comp Oncol 15(2):641–654

    PubMedGoogle Scholar

  8. Daud AI et al (2008) Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol Off J Am Soc Clin Oncol 26(36):5896–5903

    Google Scholar

  9. Davalos RV, Mir IL, Rubinsky B (2005) Tissue ablation with irreversible electroporation. Ann Biomed Eng 33(2):223–231

    PubMedGoogle Scholar

  10. Escoffre JM et al (2009) What is (still not) known of the mechanism by which electroporation mediates gene transfer and expression in cells and tissues. Mol Biotechnol 41(3):286–295

    PubMedGoogle Scholar

  11. Escoffre JM et al (2011) Electromediated formation of DNA complexes with cell membranes and its consequences for gene delivery. BBA-Biomembranes 1808(6):1538–1543

    PubMedGoogle Scholar

  12. Escoffre JM et al (2014a) Membrane disorder and phospholipid scrambling in electropermeabilized and viable cells. BBA-Biomembranes 1838(7):1701–1709

    PubMedGoogle Scholar

  13. Escoffre JM et al (2014b) Evidence for electro-induced membrane defects assessed by lateral mobility measurement of a GPi anchored protein. Eur Biophys J Biophys Lett 43(6-7):277–286

    Google Scholar

  14. Falzone L, Salomone S, Libra M (2018) Evolution of cancer pharmacological treatments at the turn of the third millennium. Front Pharmacol 9:1300

    PubMedPubMedCentralGoogle Scholar

  15. Faurie C et al (2004) Effect of electric field vectoriality on electrically mediated gene delivery in mammalian cells. BBA-Biomembranes 1665(1–2):92–100

    PubMedGoogle Scholar

  16. Faurie C et al (2010) Electro-mediated gene transfer and expression are controlled by the life-time of DNA/membrane complex formation. J Gene Med 12(1):117–125

    PubMedGoogle Scholar

  17. Frandsen SK et al (2012) Direct therapeutic applications of calcium electroporation to effectively induce tumor necrosis. Cancer Res 72(6):1336–1341

    PubMedGoogle Scholar

  18. Frandsen SK et al (2020) Calcium electroporation of equine sarcoids. Animals 10(3):517

    PubMedCentralGoogle Scholar

  19. Franklin B (1956) Farther experiments and observations in electricity. Science 123(3185):47–50

    PubMedGoogle Scholar

  20. Galant L et al (2019) Calcium electroporation: the bioelectrochemical treatment of spontaneous equine skin tumors results in a local necrosis. Bioelectrochemistry 129:251–258

    PubMedGoogle Scholar

  21. Garcia PA et al (2017) Predictive therapeutic planning for irreversible electroporation treatment of spontaneous malignant glioma. Med Phys 44(9):4968–4980

    PubMedGoogle Scholar

  22. Gehl J et al (2006) Results of the ESOPE (European Standard Operating Procedures on Electrochemotherapy) study: efficient, highly tolerable and simple palliative treatment of cutaneous and subcutaneous metastases from cancers of any histology. J Clin Oncol 24(18):464s

    Google Scholar

  23. Gehl J et al (2018) Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncol 57(7):874–882

    PubMedGoogle Scholar

  24. Golzio M, Teissie J, Rols MP (2002) Direct visualization at the single-cell level of electrically mediated gene delivery. Proc Natl Acad Sci U S A 99(3):1292–1297

    PubMedPubMedCentralGoogle Scholar

  25. Heinzerling LM et al (2001) Tumor regression induced by intratumoral injection of DNA coding for human interleukin 12 into melanoma metastases in gray horses. J Mol Med 78(12):692–702

    PubMedGoogle Scholar

  26. Henshaw JW, Yuan F (2008) Field distribution and DNA transport in solid tumors during electric field-mediated gene delivery. J Pharm Sci 97(2):691–711

    PubMedGoogle Scholar

  27. Hojman P (2010) Basic principles and clinical advancements of muscle electrotransfer. Curr Gene Ther 10(2):128–138

    PubMedGoogle Scholar

  28. Impellizeri J et al (2016) Electroporation in veterinary oncology. Vet J 217:18–25

    PubMedGoogle Scholar

  29. Kishida T et al (2003) Electrochemo-gene therapy of cancer: intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice. Mol Ther 8(5):738–745

    PubMedGoogle Scholar

  30. Maglietti F et al (2020) Electroporation as the immunotherapy strategy for cancer in veterinary medicine: state of the art in Latin America. Vaccine 8(3):537

    Google Scholar

  31. Milevoj N et al (2019) A combination of electrochemotherapy, gene electrotransfer of plasmid encoding canine IL-12 and cytoreductive surgery in the treatment of canine oral malignant melanoma. Res Vet Sci 122:40–49

    PubMedGoogle Scholar

  32. Mir LM et al (1997) First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy. Br J Cancer 76(12):1617–1622

    PubMedPubMedCentralGoogle Scholar

  33. Mir LM et al (1998) Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer 77(12):2336–2342

    PubMedPubMedCentralGoogle Scholar

  34. Monfort S et al (2012) Inactivation of Salmonella spp. in liquid whole egg using pulsed electric fields, heat, and additives. Food Microbiol 30(2):393–399

    PubMedGoogle Scholar

  35. Neumann E, Rosenheck K (1972) Permeability changes induced by electric impulses in vesicular membranes. J Membr Biol 10(3):279–290

    PubMedGoogle Scholar

  36. Neumann E et al (1982) Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1(7):841–845

    PubMedPubMedCentralGoogle Scholar

  37. Niessen C et al (2012) Ablation of a liver metastasis with irreversible electroporation (IRE) in liver segment II adjoining the area nuda. RoFo 184(10):937–938

    PubMedGoogle Scholar

  38. Okino M, Mohri H (1987) Effects of a high-voltage electrical impulse and an anticancer drug on in vivo growing tumors. Jpn J Cancer Res Gann 78(12):1319–1321

    PubMedGoogle Scholar

  39. Orlowski S et al (1988) Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 37(24):4727–4733

    PubMedGoogle Scholar

  40. Paganin-Gioanni A et al (2011) Direct visualization at the single-cell level of siRNA electrotransfer into cancer cells. Proc Natl Acad Sci U S A 108(26):10443–10447

    PubMedPubMedCentralGoogle Scholar

  41. Parniakov O et al (2016) Extraction assisted by pulsed electric energy as a potential tool for green and sustainable recovery of nutritionally valuable compounds from mango peels. Food Chem 192:842–848

    PubMedGoogle Scholar

  42. Pasquet L et al (2019) Pre-clinical investigation of the synergy effect of interleukin-12 gene-electro-transfer during partially irreversible electropermeabilization against melanoma. J Immunother Cancer 7:161

    PubMedPubMedCentralGoogle Scholar

  43. Pirc E, Miklavcic D, Rebersek M (2019) Nanosecond pulse electroporator with silicon carbide mosfets: development and evaluation. IEEE Trans Biomed Eng 66(12):3526–3533

    PubMedGoogle Scholar

  44. Puertolas E et al (2009) Pulsed electric fields inactivation of wine spoilage yeast and bacteria. Int J Food Microbiol 130(1):49–55

    PubMedGoogle Scholar

  45. Rebersek M et al (2007) Electroporator with automatic change of electric field direction improves gene electrotransfer in-vitro. Biomed Eng Online 6:25

    PubMedPubMedCentralGoogle Scholar

  46. Rols MP (2006) Electropermeabilization, a physical method for the delivery of therapeutic molecules into cells. BBA-Biomembranes 1758(3):423–428

    PubMedGoogle Scholar

  47. Rols MP, Femenia P, Teissie J (1995) Long-lived macropinocytosis takes place in electropermeabilized mammalian-cells. Biochem Biophys Res Commun 208(1):26–35

    PubMedGoogle Scholar

  48. Rols MP et al (1998) In vivo electrically mediated protein and gene transfer in murine melanoma. Nat Biotechnol 16(2):168–171

    PubMedGoogle Scholar

  49. Rols MP, Tamzali Y, Teissie J (2002) Electrochemotherapy of horses. A preliminary clinical report. Bioelectrochemistry 55(1-2):101–105

    PubMedGoogle Scholar

  50. Romeo S et al (2018) ESOPE-equivalent pulsing protocols for calcium electroporation: an in vitro optimization study on 2 cancer cell models. Technol Cancer Res Treat 17:1533033818788072

    PubMedPubMedCentralGoogle Scholar

  51. Rosazza C et al (2011) The actin cytoskeleton has an active role in the electrotransfer of plasmid DNA in mammalian cells. Mol Ther 19(5):913–921

    PubMedPubMedCentralGoogle Scholar

  52. Rosazza C et al (2013) Intracellular tracking of single-plasmid DNA particles after delivery by electroporation. Mol Ther 21(12):2217–2226

    PubMedPubMedCentralGoogle Scholar

  53. Rosazza C et al (2016) Endocytosis and endosomal trafficking of DNA after gene electrotransfer in vitro. Mol Ther Nucleic Acids 5:1–11

    Google Scholar

  54. Ruarus AH et al (2020) Irreversible electroporation for hepatic tumors: protocol standardization using the modified delphi technique. J Vasc Interv Radiol 31(11):1765–1771 e15

    PubMedGoogle Scholar

  55. Salvadori C et al (2017) Effects of electrochemotherapy with cisplatin and peritumoral IL-12 gene electrotransfer on canine mast cell tumors: a histopathologic and immunohistochemical study. Radiol Oncol 51(3):286–294

    PubMedPubMedCentralGoogle Scholar

  56. Scheltema MJ et al (2019) Numerical simulation modeling of the irreversible electroporation treatment zone for focal therapy of prostate cancer, correlation with whole-mount pathology and T2-weighted MRI sequences. Ther Adv Urol 11:1756287219852305

    PubMedPubMedCentralGoogle Scholar

  57. Schicho A et al (2019) Long-term survival after percutaneous irreversible electroporation of inoperable colorectal liver metastases. Cancer Manag Res 11:317–322

    PubMedGoogle Scholar

  58. Spugnini EP, Baldi A (2019) Electrochemotherapy in veterinary oncology: state-of-the-art and perspectives. Vet Clin North Am Small Anim Pract 49(5):967–979

    PubMedGoogle Scholar

  59. Tamzali Y, Teissie J, Rols MP (2001) Cutaneous tumor treatment by electrochemotherapy: preliminary clinical results in horse sarcoids. Rev Med Vet 152(8–9):605

    Google Scholar

  60. Tamzali Y et al (2012) Successful treatment of equine sarcoids with cisplatin electrochemotherapy: a retrospective study of 48 cases. Equine Vet J 44(2):214–220

    PubMedGoogle Scholar

  61. Teissie J, Rols MP (1986) Fusion of mammalian-cells in culture is obtained by creating the contact between cells after their electropermeabilization. Biochem Biophys Res Commun 140(1):258–266

    PubMedGoogle Scholar

  62. Teissie J, Rols MP (1993) An experimental evaluation of the critical potential difference inducing cell-membrane electropermeabilization. Biophys J 65(1):409–413

    PubMedPubMedCentralGoogle Scholar

  63. Teissie J et al (1982) Electric pulse-induced fusion of 3t3 cells in monolayer-culture. Science 216(4545):537–538

    PubMedGoogle Scholar

  64. Teissie J, Golzio M, Rols MP (2005) Mechanisms of cell membrane electropermeabilization: a minireview of our present (lack of ?) knowledge. BBA-Gen Subjects 1724(3):270–280

    Google Scholar

  65. Torrero MN, Henk WG, Li S (2006) Regression of high-grade malignancy in mice by bleomycin and interleukin-12 electrochemogenetherapy. Clin Cancer Res 12(1):257–263

    PubMedGoogle Scholar

  66. Tozon N et al (2016) Operating procedures of the electrochemotherapy for treatment of tumor in dogs and cats. J Vis Exp 116:54760

    Google Scholar

  67. Yarmush ML et al (2014) Electroporation-based technologies for medicine: principles, applications, and challenges. Annu Rev Biomed Eng 16:295–320

    PubMedGoogle Scholar

  68. Zelbstein MU (1984) Not available. Hist Sci Med 18(3):295–306

    PubMedGoogle Scholar

Copyright information

© The Author(s), under exclusive license to Springer Nature Switzerland AG 2021

Authors and Affiliations

  1. 1.Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPSToulouseFrance

Read more here: Source link